Verification of Shear Wave Elastography for DEtection of Prostate Cancer
NCT04836949 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170
Last updated 2021-04-08
Summary
1. Objective To provide evidence that adding shear wave elastography during sono-guided prostate biopsy can increase prostate cancer detection rate and to demonstrate that shear wave elastography of the prostate can discriminate malignant lesions to reduce the number of unnecessary prostate biopsies.
2. Overview Patients who are indicated for prostate biopsy in suspicion of prostate cancer will be assigned to a control group and an intervention group under double blinded randomization.
* Control group : Patients will undergo prostate biopsy guided by conventional ultrasonography (B mode, gray scale).
* Experimental group : Patients will undergo prostate biopsy guided by shear wave elastography in addition to conventional ultrasonography.
A comparative statistical analysis of the two groups will be performed.
The study is planned to be conducted for 3 years, with 2 years for patient enrollment and 1 year of follow-up. Three hospitals will participate in the study to enroll 85 patients for each group and a total of 170 patients.
3\. Inclusion and Exclusion criteria
* Male patients with suspected prostate cancer must meet at least one of the following three criteria.
1. PSA level over 4ng/dl
2. Suspicious hard prostatic nodule on digital rectal examination.
3. Hypoechoic lesion on ultrasound of the prostate suspicious for cancer.
* Patients who (1) are less than 20 years old, (2) have a history of surgery on the prostate such as HoLEP, (3) have moderate cognitive impairment, or (4) have medical conditions precluding transrectal procedures such as rectal cancer are excluded from the study.
4\. Research method
* Patients who wish to participate in this study and meet the inclusion/exclusion criteria are randomly assigned to the 2 groups as described above.
* The biopsy results are checked one week after the procedure.
* Patients confirmed to have prostate cancer are provided proper treatment according to generally accepted treatment methods.
* Patients with negative biopsy results are followed according to general follow-up protocol for suspected prostate cancer patients. After 6 months from the biopsy the patients are re-evaluated and if cancer is still suspected based on PSA level or other clinical symptoms, prostate MRI or additional biopsy is be performed.
* Patients are followed again after 12 months since the initial biopsy with identical methods from the 6 months follow-up protocol.
Conditions
- Prostatic Neoplasms
Interventions
- DEVICE
-
Shear Wave Elastography of prostate
A 12-core template biopsy is planned as during a conventional prostate biopsy. The prostate is divided in to 1) Rt apex, 2) Rt mid, 3) Rt base, 4) Rt apex lateral, 5) Rt mid lateral, 6) Rt base lateral, 7) Lt apex, 8) Lt mid, 9) Lt base, 10) Lt apex lateral, 11) Lt mid lateral, and 12) Lt base lateral areas. The elasticity of each area is evaluated and region with the maximum Young's modulus value is selected and targeted for biopsy. Additional biopsy for suspicious lesions can be performed at the discretion of the practitioner.
- DEVICE
-
Conventional Prostate Ultrasound
A conventional 12-core template biopsy is planned. The prostate is divided in to 1) Rt apex, 2) Rt mid, 3) Rt base, 4) Rt apex lateral, 5) Rt mid lateral, 6) Rt base lateral, 7) Lt apex, 8) Lt mid, 9) Lt base, 10) Lt apex lateral, 11) Lt mid lateral, and 12) Lt base lateral areas. Random biopsy of each area is performed. Additional biopsy of suspicious hypoechoic nodular lesions can be performed at the discretion of the practitioner.
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Principal Investigators
-
Woong Kyu Han · Severance Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 90 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-03
- Primary Completion
- 2023-12-08
- Completion
- 2024-02-01
Countries
- South Korea
Study Locations
More Related Trials
-
A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy
NCT01748890 ·Status: TERMINATED ·Phase: NA
-
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
NCT04981223 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device
NCT02524860 ·Status: UNKNOWN ·Phase: NA
-
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
NCT07075705 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multiparametric Ultrasound-Study for the Detection of Prostate Cancer
NCT03091231 ·Status: COMPLETED
-
Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample
NCT01692405 ·Status: COMPLETED ·Phase: NA
-
Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CT
NCT04846894 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy
NCT03013413 ·Status: COMPLETED ·Phase: NA
-
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946 ·Status: UNKNOWN ·Phase: NA
-
Cancer Diagnosis by Multiparametric UltraSound of the Prostate
NCT02712684 ·Status: UNKNOWN
-
Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
NCT05761912 ·Status: ACTIVE_NOT_RECRUITING
-
Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer
NCT01764347 ·Status: COMPLETED ·Phase: NA
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision
NCT06281769 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Based Transperineal Robotic Biopsy of the the Prostate
NCT01102361 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
NCT03908684 ·Status: RECRUITING
-
Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate Cancer
NCT03615131 ·Status: COMPLETED
-
Salvage Prostatectomy After Radiotherapy
NCT00791115 ·Status: COMPLETED ·Phase: NA
-
Fusion Targeted Biopsy of the Prostate
NCT02013414 ·Status: COMPLETED ·Phase: NA
-
MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy
NCT05471128 ·Status: ACTIVE_NOT_RECRUITING
-
Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer
NCT02079025 ·Status: COMPLETED ·Phase: NA
-
The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer
NCT03418207 ·Status: UNKNOWN ·Phase: NA
-
Prostate Biopsies With Target Lesion on MRI
NCT04692207 ·Status: COMPLETED
-
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer
NCT01686958 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
NCT06584279 ·Status: RECRUITING